If I read it correctly - it works better than temozolomide (the SOC) for that patient group, i.e patients who are resistant to temozolomide. Not patients temozolomide does work in. More than happy to be corrected.
- Forums
- ASX - By Stock
- Ann: Kazia releases final data from P2 paxalisib trial
If I read it correctly - it works better than temozolomide (the...
-
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online